Can 3M Navigate Legal Risks to Sustain Recent Gains?
July 12, 2025 Netflix Stock Analysis: Is the King Still Reigning?
July 11, 2025 The Harsh Truth: Saving Won’t Make You Rich
July 10, 2025 Moving Out of State from Rockville? Start Here
July 10, 2025 Drive Like Royalty: Best Exotic Cars to Rent in Monaco in 2025
July 10, 2025 2025 Altseason: The Next Frontier in Crypto Growth
Fulcrum Therapeutics (FULC) stock forecast for 2025
Updated: June 3, 2025 (13:52)
Sector: HealthcareThe share price of Fulcrum Therapeutics, Inc. (FULC) now
50/200 Day Moving Average: $4.335 / $4.405
This figure corresponds to the Average Price over the previous 50/200 days. For Fulcrum Therapeutics stocks, the 50-day moving average is the resistance level today.
For Fulcrum Therapeutics stocks, the 200-day moving average is the resistance level today.
Are you interested in Fulcrum Therapeutics, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Fulcrum Therapeutics stock price in 2025. How much will one Fulcrum Therapeutics share be worth in 2025? Is it worth taking profit / loss on FULC stock now or waiting? What are analysts' forecasts for Fulcrum Therapeutics stock?
We forecast Fulcrum Therapeutics stock performance using neural networks based on historical data on FULC stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
Fulcrum Therapeutics, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Fulcrum Therapeutics analysts is $7.57. Today 200 Day Moving Average is the support level (4.405 $). 50 Day Moving Average is the support level (4.335 $).
Historical and forecast chart of Fulcrum Therapeutics, Inc. stock
The chart below shows the historical price of Fulcrum Therapeutics stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the FULC stock price can be found in the table below.
Fulcrum Therapeutics is a biopharmaceutical company that develops drugs to treat genetic diseases. The company has developed product candidates to modulate gene expression and potentially treat the underlying cause of these diseases.
Fulcrum Therapeutics (FULC) Forecast for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jul | 7.78 | 6.85 | 9.01 | 24.01 % |
| Aug | 8.68 | 7.83 | 10.02 | 21.84 % |
| Sep | 8.89 | 7.88 | 9.62 | 18.11 % |
| Oct | 9.14 | 8.15 | 9.65 | 15.53 % |
| Nov | 9.53 | 8.86 | 10.94 | 18.99 % |
| Dec | 8.93 | 8.06 | 9.56 | 15.70 % |
Fulcrum Therapeutics information and performance
26 LANDSDOWNE STREET, CAMBRIDGE, MA, US
Market capitalization of the Fulcrum Therapeutics, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of FULC shares in the company outstanding by the market price of one share.
EBITDA of Fulcrum Therapeutics is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Fulcrum Therapeutics price target for 2025 by month
Target values for the price of one Fulcrum Therapeutics share for Jul 2025.
In Jul, the Positive dynamics for Fulcrum Therapeutics, Inc. shares will prevail with possible monthly volatility of 24.007% volatility is expected.
Pessimistic target level: 6.85
Optimistic target level: 9.01
Target values for the price of one Fulcrum Therapeutics share for Aug 2025.
In Aug, the Positive dynamics for Fulcrum Therapeutics, Inc. shares will prevail with possible monthly volatility of 21.837% volatility is expected.
Pessimistic target level: 7.83
Optimistic target level: 10.02
Target values for the price of one Fulcrum Therapeutics share for Sep 2025.
In Sep, the Positive dynamics for Fulcrum Therapeutics, Inc. shares will prevail with possible monthly volatility of 18.115% volatility is expected.
Pessimistic target level: 7.88
Optimistic target level: 9.62
Target values for the price of one Fulcrum Therapeutics share for Oct 2025.
In Oct, the Positive dynamics for Fulcrum Therapeutics, Inc. shares will prevail with possible monthly volatility of 15.530% volatility is expected.
Pessimistic target level: 8.15
Optimistic target level: 9.65
Target values for the price of one Fulcrum Therapeutics share for Nov 2025.
In Nov, the Positive dynamics for Fulcrum Therapeutics, Inc. shares will prevail with possible monthly volatility of 18.990% volatility is expected.
Pessimistic target level: 8.86
Optimistic target level: 10.94
Target values for the price of one Fulcrum Therapeutics share for Dec 2025.
In Dec, the Negative dynamics for Fulcrum Therapeutics, Inc. shares will prevail with possible monthly volatility of 15.701% volatility is expected.
Pessimistic target level: 8.06
Optimistic target level: 9.56
Related stocks from Healthcare sector
